326
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Interest and preferences for contingency management design among addiction treatment clientele

, PhD & , MA, MPH
Pages 287-295 | Received 13 May 2015, Accepted 15 Sep 2015, Published online: 08 Dec 2015

References

  • Institute of Medicine (IOM). Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment. Washington, DC: IOM; 1998.
  • Hanson GR, Leshner AI, Tai B. Putting drug abuse research to use in real-life settings. J Subst Abuse Treat 2002;23:69–70.
  • Peirce J, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vasquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino M, Kolodner K. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network Study. Arch Gen Psychiatry 2006;63:201–208.
  • Petry NM, Peirce J, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2005;62:1148–1156.
  • Hartzler B, Lash SJ, Roll JM. Vouchers, prizes, and clinic privileges as reinforcement for abstinence: a review of the efficacy of contingency management applications. Hollywood, FL: College on Problems of Drug Dependence; 2011.
  • Petry NM. Contingency management for substance abuse treatment: A guide to implementing this evidence-based practice. New York: Routledge; 2012.
  • Prendergast M, Podus D, Finney JW, Greenwell L, Roll JM. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006;101:1546–1560.
  • Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006;101:192–203.
  • Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, Festinger DS. Prize-based contingency management for the treatment of substance abusers: A meta-analysis. Addiction 2014;109:1426–1436.
  • Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008;165: p.179–187.
  • Kirby KC, Benishek LA, Dugosh KL, Kerwin ME. Substance abuse treatment providers’ beliefs and objections regarding contingency management: Implications for dissemination. Drug Alcohol Depend 2006;85:19–27.
  • Roll JM, Madden GJ, Rawson R, Petry NM. Facilitating the adoption of contingency management for the treatment of substance use disorders. Behav Analysis Pract 2009;2:4–13.
  • Spring B. Evidence-based practice in clinical psychology: What it is, why it matters, what you need to know. J Clin Psychol 2007;63:611–631.
  • Higgins ST, Silverman K, Heil SH. Contingency management in substance abuse treatment. New York: Guilford; 2008.
  • Ritter A, Cameron J. Australian clinician attitudes towards contingency management: Comparing down under with America. Drug Alcohol Depend 2007;87:312–315.
  • Hartzler B, Rabun C. Community treatment perspectives on contingency management: A mixed-method approach to examining feasibility, effectiveness, and transportability. J Subst Abuse Treat 2013;45:242–248.
  • Higgins ST, Budney AJ, Bickel WK, Hughes JR, Roerg F, Badger GJ. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993;150:763–769.
  • Higgins ST, Budney AJ, Bickel WK, Hughes J, Foerg FE, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994;51:568–576.
  • Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000;68:250–257.
  • Petry NM, DePhillipis D, Rash CJ, Drapkin M, McKay JR. Nationwide dissemination of contingency management: The Veterans Administration Initiative. Am JAddictions 2014;23:205–210.
  • Squires DD, Gumbley SJ, Storti SA. Training substance abuse treatment organizations to adopt evidence-based practices: The Addiction Transfer Center of New England Science-to-Service Laboratory. J Subst Abuse Treat 2008;34:293–301.
  • Kellogg SH, Burns M, Coleman P, Stitzer ML, Wale JB, Kreek MJ. Something of value: The introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service. J Subst Abuse Treat 2005;28:57–65.
  • Hartzler B. Building a bonfire that remains stoked: Sustainment of a contingency management intervention through collaborative design. Subst Abuse Treat Prevent Policy 2015;10:30.
  • Hartzler B, Jackson TR, Jones BE, Beadnell B, Calsyn DA. Disseminating contingency management: Impacts of staff training and implementation at an opiate treatment program. J Substance Abuse Treat 2014;46:429–438.
  • Stitzer ML, Bigelow GE. Contingency management in a methadone maintenance program: Availability of reinforcers. Int Jn Addictions 1978;13:737–746.
  • Yen S. Availability of activity reinforcers in a drug abuse clinic: A preliminary report. Psycholog Rep 1974;34:1021–1022.
  • Amass L, Bickel WK, Crean JP, Higgins ST. Preferences for clinic privileges, retail items, and social activities in an outpatient buprenorphine treatment program. J Subst Abuse Treat 1996;13:43–49.
  • Schmitz JM, Rhoades HM, Grabowski J. A menu of potential reinforcers in a methadone maintenance program. J Subst Abuse Treat 1994;11:425–431.
  • Chutuape MA, Silverman K, Stitzer ML. Survey assessment of methadone treatment services as reinforcers. Am J Drug Alcohol Abuse 1998;24:1–16.
  • Kidorf M, Stitzer ML, Griffiths RR. Evaluating the reinforcement value of clinic-based privileges through a multiple-choice procedure. Drug Alcohol Depend 1995;39:167–172.
  • Reilly MP, Roll JM, Downey KK. Impulsivity and voucher versus money preference in polydrug-dependent participants enrolled in a contingency-management-based substance abuse treatment program. J Subst Abuse Treat 2000;19:253–257.
  • Roll JM, Chudzynski JE, Richardson G. Potential sources of reinforcement and punishment in a drug-free treatment clinic: Client and staff perceptions. Am J Drug Alcohol Abuse 2005;1:21–33.
  • Barry D, Sullivan B, Petry NM. Comparable efficacy of contingency management for cocaine-dependence among African American, Hispanic, and White methadone maintenance clients. Psychol Addictive Behav 2009;23:168–174.
  • Weinstock J, Alessi SM, Petry NM. Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes. Drug Alcohol Depend 2007;87:288–296.
  • Rash CJ, Alessi SM, Petry NM. Contingency management is efficacious for cocaine abusers with prior treatment attempts. Experim Clin Psychopharmacol 2008;16:547–554.
  • Rash CJ, Olmstead TA, Petry NM. Income does not affect response to contingency management treatments among community substance abuse treatment-seekers. Drug Alcohol Depend 2009;104:249–253.
  • Rash CJ, Andrade LF, Petry NM. Income received during treatment does not affect response to contingency management treatments in cocaine-dependent outpatients. Drug Alcohol Depend 2013;132:528–534.
  • Secades-Villa R, Garcia-Fernandez G, Pena-Suarez E, Garcia-Rodriguez O, Sanchez-Hervas E, Fernandez-Hermida JR. Contingency management is effective across cocaine-dependent outpatients with different socioeconomic status. J Subst Abuse Treat 2013;44:349–354.
  • Hartzler B, Donovan DM, Huang Z. Comparison of opiate-primary treatment-seekers with and without alcohol use disorder. J Subst Abuse Treat 2010;39:114–123.
  • Hartzler B, Donovan DM, Huang Z. Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: Meta-analytic findings across eight NIDA CTN trials. Am J Drug Alcohol Abuse 2011;37:460–471.
  • Weiss LM, Petry NM. Interaction effects of age and contingency management treatment in cocaine-dependent outpatients. Experim Clin Psychopharmacol 2011;19:173–181.
  • Weiss LM, Petry NM. Older methadone patients achieve greater durations of cocaine abstinence with contingency management than younger patients. Am J Addiction 2013;22:119–126.
  • Weiss LM, Petry NM. Substance abuse treatment patients with early onset cocaine use respond as well to contingency management interventions as those with later onset cocaine use. J Subst Abuse Treat 2014;47:146–150.
  • Hser Y, Joshi V, Maglione M, Chou C, Anglin MD. Effects of patient characteristics on retention of drug treatment patients. Evaluat Program Planning 2001;24:331–341.
  • Sinha R, Easton C, Kemp K. Substance abuse treatment characteristics of probation-referred young adults in a community-based outpatient program. Am J Drug Alcohol Abuse 2003;29:585–597.
  • Shin S, Lundgren L, Chassler D. Examining drug treatment entry pattens among young injections drug users. Am J Drug Alcohol Abuse 2007;33:217–225.
  • Mertens JR, Weisner CM. Predictors of substance abusertreatment retention among women and men in an HMO. Alcoholism: Clin Experim Res 2000;24:1525–1533.
  • Walton MA, Blow FC, Bingham CR, Chermack ST. Individual and social/environmental predictors of alcohol and drug use 2 years following substance abuse treatment. Addictive Behav 2003;28:627–642.
  • Rash CJ, Petry NM. Contingency management treatments are equally efficacious for both sexes in intensive outpatient settings. Experim Clin Psychopharmacol 2015;23:369–376.
  • Brady TM, Ashley OS. Women in substance abuse treatment: results from the Alcohol and Drug Services Study (ADSS), in Analytic Series A-262005, Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
  • Grella CE, Joshi V, Hser Y. Program variation in treatment outcomes among women in residential drug treatment. Evaluat Rev 2000;24:364–383.
  • Wechsber WM, Luseno W, Ellerson R. Reaching women substance abusers in diverse settings: Stigma and access to treatment 30 years later. Subst Use Misuse 2008;43:1277–1279.
  • Bickel WK, Miller ML, Yi R, Kowal BP, Lindquist DM, Pitcock JA. Behavioral and neuroeconomics of drug addiction: Competing neural systems and temporal discounting processes. Drug Alcohol Depend 2007;90:S85–91.
  • Hartzler B, Rabun C. Community treatment adoption of contingency management: A conceptual profile of U.S. clinics based on innovativeness of executive staff. Int J Drug Policy 2013;24:333–341.
  • Bauer DJ, Curran PJ. Introduction to multilevel modeling, L.L.C. Curran-Bauer Analytics, Editor 2012, www.cbanalytics.org.
  • Olmstead TA, Petry NM. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend 2009;102:108–115.
  • Ainslie G, Haslam N. Hyperbolic discounting. In: Loewenstein GE, Elster J, editors. Choice over time. New York: Russell Sage Foundation; 1992. pp 57–92.
  • Hartzler B, Lash SJ, Roll JM. Contingency management in substance abuse treatment: a structured review of the evidence for its transportability. Drug Alcohol Depend 2012;122:1–10.
  • Kendall PC, Beidas RS. Smoothing the trail for dissemination of evidence-based practices for youth: Flexibility within fidelity. Prof Psychol: Res Pract 2007;38:13–20.
  • Carroll KM. Treatment integrity and dissemination: rethinking fidelity via the stage model. Clin Psychol Sci Pract 2013;20:99–106.
  • Chivers LL, Higgins ST. Some observations from behavioral economics for consideration in promoting money management among those with substance abuse disorders. Am J Drug Alcohol Abuse 2012;38:8–19.
  • Ducharme LJ, Knudsen HK, Abraham AJ, Roman PM. Counselor attitudes toward the use of motivational incentives in addiction treatment. Am J Addiction 2010;19:496–503.
  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Medical Care 2012;50:217–226.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.